Danish drugmaker reaches settlement with US authorities
COPENHAGEN, Denmark (AP) - Danish drug maker Novo Nordisk says it has reached a $46.5 million settlement with U.S. authorities over allegations that it hadn't properly communicated safety information when marketing a medicine to treat type 2 diabetes.
Читать дальше...